Skip to main content
Top
Published in: Journal of Neuro-Oncology 1/2007

01-03-2007 | Lab Investigation

Evaluation of molecular genetic alterations associated with tumor progression in a case of gliomatosis cerebri

Authors: Stefan Braeuninger, Regine Schneider-Stock, Elmar Kirches, James M. Powers, David N. Korones, Christian Mawrin

Published in: Journal of Neuro-Oncology | Issue 1/2007

Login to get access

Abstract

Gliomatosis cerebri (GC) is a rare tumor characterized by widespread infiltration of the brain and spinal cord. Although GC usually demonstrates histomorphological features of a low-grade tumor, the formation of secondary highly malignant tumor regions may occur. In order to reveal molecular genetic changes associated with tumor progression in GC, we analyzed factors known to be associated with malignant progression in common astocytomas in an unusual GC case of an 18-year-old patient suffering from this disease for almost 7 years. We detected allelic losses in the Rb gene and in exon 4 of the TP53 gene in a tumor region corresponding to a glioblastoma multiforme. EGFR or MDM2 gene amplifications were absent, and no PTEN mutation or allelic loss on chromosome 10 could be detected. Moreover, compared to tumor-free brain tissue of this patient, tumor regions showed increased EGFR expression. These findings show that malignant progression in GC might be associated with the acquisition of molecular genetic changes also found in low-grade astrocytomas with progression to secondary glioblastoma. These data support the notion that GC can be regarded as a subtype of a common astrocytoma.
Literature
1.
go back to reference Kleihues P, Cavenee WK (2000) WHO Classification of tumours: Pathology and genetics of tumours of the nervous system. IARC Press, Lyon Kleihues P, Cavenee WK (2000) WHO Classification of tumours: Pathology and genetics of tumours of the nervous system. IARC Press, Lyon
2.
go back to reference Cummings TJ, Hulette CM, Longee DC, Bottom KS, McLendon RE, Chu CT (1999) Gliomatosis cerebri: cytologic and autopsy findings in a case involving the entire neuraxis. Clin Neuropathol 18:190–197PubMed Cummings TJ, Hulette CM, Longee DC, Bottom KS, McLendon RE, Chu CT (1999) Gliomatosis cerebri: cytologic and autopsy findings in a case involving the entire neuraxis. Clin Neuropathol 18:190–197PubMed
3.
go back to reference Mawrin C, Aumann V, Kirches E, Schneider-Stock R, Scherlach C, Vogel S, Mittler U, Dietzmann K, Krause G, Weis S (2001) Gliomatosis cerebri: post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide. J Neurooncol 55:11–17PubMedCrossRef Mawrin C, Aumann V, Kirches E, Schneider-Stock R, Scherlach C, Vogel S, Mittler U, Dietzmann K, Krause G, Weis S (2001) Gliomatosis cerebri: post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide. J Neurooncol 55:11–17PubMedCrossRef
4.
go back to reference Schober R, Mai JK, Volk B, Wechsler W (1991) Gliomatosis cerebri: bioptical approach and neuropathological verification. Acta Neurochir (Wien) 113:131–137CrossRef Schober R, Mai JK, Volk B, Wechsler W (1991) Gliomatosis cerebri: bioptical approach and neuropathological verification. Acta Neurochir (Wien) 113:131–137CrossRef
5.
go back to reference Balko MG, Blisard KS, Samaha FJ (1992) Oligodendroglial gliomatosis cerebri. Hum Pathol 23:706–707PubMedCrossRef Balko MG, Blisard KS, Samaha FJ (1992) Oligodendroglial gliomatosis cerebri. Hum Pathol 23:706–707PubMedCrossRef
6.
go back to reference Tancredi A, Mangiola A, Guiducci A, Peciarolo A, Ottaviano P (2000) Oligodendrocytic gliomatosis cerebri. Acta Neurochir (Wien) 142:469–472CrossRef Tancredi A, Mangiola A, Guiducci A, Peciarolo A, Ottaviano P (2000) Oligodendrocytic gliomatosis cerebri. Acta Neurochir (Wien) 142:469–472CrossRef
7.
go back to reference Jennings MT, Frenchman M, Shehab T, Johnson MD, Creasy J, LaPorte K, Dettbarn WD (1995) Gliomatosis cerebri presenting as intractable epilepsy during early childhood. J Child Neurol 10:37–45PubMedCrossRef Jennings MT, Frenchman M, Shehab T, Johnson MD, Creasy J, LaPorte K, Dettbarn WD (1995) Gliomatosis cerebri presenting as intractable epilepsy during early childhood. J Child Neurol 10:37–45PubMedCrossRef
8.
go back to reference Kannuki S, Hirose T, Horiguchi H, Kageji T, Nagahiro S (1998) Gliomatosis cerebri with secondary glioblastoma formation: report of two cases. Brain Tumor Pathol 15:111–116PubMedCrossRef Kannuki S, Hirose T, Horiguchi H, Kageji T, Nagahiro S (1998) Gliomatosis cerebri with secondary glioblastoma formation: report of two cases. Brain Tumor Pathol 15:111–116PubMedCrossRef
9.
go back to reference Mawrin C, Lins H, Kirches E, Schildhaus HU, Scherlach C, Kanakis D, Dietzmann K (2003) Distribution of p53 alterations in a case of gliomatosis cerebri. Hum Pathol 34:102–106PubMedCrossRef Mawrin C, Lins H, Kirches E, Schildhaus HU, Scherlach C, Kanakis D, Dietzmann K (2003) Distribution of p53 alterations in a case of gliomatosis cerebri. Hum Pathol 34:102–106PubMedCrossRef
10.
go back to reference Herrlinger U, Felsberg J, Küker W, Bornemann A, Plasswilm L, Knobbe CB, Strik H, Wick W, Meyermann R, Dichgans J, Bamberg M, Reifenberger G, Weller M (2002) Gliomatosis cerebri: molecular pathology and clinical course. Ann Neurol 52:390–399PubMedCrossRef Herrlinger U, Felsberg J, Küker W, Bornemann A, Plasswilm L, Knobbe CB, Strik H, Wick W, Meyermann R, Dichgans J, Bamberg M, Reifenberger G, Weller M (2002) Gliomatosis cerebri: molecular pathology and clinical course. Ann Neurol 52:390–399PubMedCrossRef
11.
go back to reference Kros JM, Zheng P, Dinjens WNM, Alers JC (2002) Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis. J Neuropathol Exp Neurol 61:806–814PubMed Kros JM, Zheng P, Dinjens WNM, Alers JC (2002) Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis. J Neuropathol Exp Neurol 61:806–814PubMed
12.
go back to reference Mawrin C, Kirches E, Schneider-Stock R, Scherlach C, Vorwerk C, von Deimling A, van Landeghem F, Meyermann R, Bornemann A, Mueller A, Romeike B, Stoltenburg-Didinger G, Wickboldt J, Pilz P, Dietzmann K (2003) Analysis of TP53 and PTEN in gliomatosis cerebri. Acta Neuropathol (Berl) 105:529–536 Mawrin C, Kirches E, Schneider-Stock R, Scherlach C, Vorwerk C, von Deimling A, van Landeghem F, Meyermann R, Bornemann A, Mueller A, Romeike B, Stoltenburg-Didinger G, Wickboldt J, Pilz P, Dietzmann K (2003) Analysis of TP53 and PTEN in gliomatosis cerebri. Acta Neuropathol (Berl) 105:529–536
13.
go back to reference Kleihues P, Ohgaki H (1999) Primary and secondary glioblastomas: from concept to clinical diagnosis. Neurooncology 1:44–51 Kleihues P, Ohgaki H (1999) Primary and secondary glioblastomas: from concept to clinical diagnosis. Neurooncology 1:44–51
14.
go back to reference Mawrin C, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Deimling A, Stoltenburg-Didinger G, Bornemann A, Romeike B, Sellhaus B, Dietzmann K (2005) Alterations of cell cycle regulators in gliomatosis cerebri. J Neurooncol 72:115–122PubMedCrossRef Mawrin C, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Deimling A, Stoltenburg-Didinger G, Bornemann A, Romeike B, Sellhaus B, Dietzmann K (2005) Alterations of cell cycle regulators in gliomatosis cerebri. J Neurooncol 72:115–122PubMedCrossRef
15.
go back to reference Schneider-Stock R, Mawrin C, Motsch C, Boltze C, Peters B, Hartig R, Buhtz P, Giers A, Rohrbeck A, Freigang B, Roessner A (2004) Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol 164:1233–1241PubMed Schneider-Stock R, Mawrin C, Motsch C, Boltze C, Peters B, Hartig R, Buhtz P, Giers A, Rohrbeck A, Freigang B, Roessner A (2004) Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol 164:1233–1241PubMed
16.
go back to reference Mawrin C, Kirches E, Boltze C, Dietzmann K, Roessner A, Schneider-Stock R (2002) Immunohistochemical and molecular analysis of p53, RB, and PTEN in malignant peripheral nerve sheath tumors. Virchows Arch 440:610–615PubMedCrossRef Mawrin C, Kirches E, Boltze C, Dietzmann K, Roessner A, Schneider-Stock R (2002) Immunohistochemical and molecular analysis of p53, RB, and PTEN in malignant peripheral nerve sheath tumors. Virchows Arch 440:610–615PubMedCrossRef
17.
go back to reference Foerster O, Gagel O (1934) Zentrale diffuse Schwannose bei Recklinghausenscher Krankheit. Z Gesamte Neurol Psychiatr 151:1–16 Foerster O, Gagel O (1934) Zentrale diffuse Schwannose bei Recklinghausenscher Krankheit. Z Gesamte Neurol Psychiatr 151:1–16
19.
go back to reference Kluwe L, Friedrich RE, Mautner VF (1999) Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas. Cancer Genet Cytogenet 113:65–69PubMedCrossRef Kluwe L, Friedrich RE, Mautner VF (1999) Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas. Cancer Genet Cytogenet 113:65–69PubMedCrossRef
20.
go back to reference Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu HJ, Benedict WF, Yandell DW, Louis DN (1994) The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 36:714–721PubMedCrossRef Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu HJ, Benedict WF, Yandell DW, Louis DN (1994) The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 36:714–721PubMedCrossRef
21.
go back to reference James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP, Cavenee WK (1988) Clonal genomic alterations in glioma malignancy stages. Cancer Res 48:5546–5551PubMed James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP, Cavenee WK (1988) Clonal genomic alterations in glioma malignancy stages. Cancer Res 48:5546–5551PubMed
22.
go back to reference Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19:1092–1100PubMed Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19:1092–1100PubMed
23.
go back to reference Dumont P, Leu JI, Della Pietra AC, George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357–365PubMedCrossRef Dumont P, Leu JI, Della Pietra AC, George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357–365PubMedCrossRef
Metadata
Title
Evaluation of molecular genetic alterations associated with tumor progression in a case of gliomatosis cerebri
Authors
Stefan Braeuninger
Regine Schneider-Stock
Elmar Kirches
James M. Powers
David N. Korones
Christian Mawrin
Publication date
01-03-2007
Published in
Journal of Neuro-Oncology / Issue 1/2007
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-006-9245-7

Other articles of this Issue 1/2007

Journal of Neuro-Oncology 1/2007 Go to the issue

Clinical–Patient Studies

Psammomatoid ossifying fibroma